Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer’s Disease Patients with Depressive Symptoms
Journal article

Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer’s Disease Patients with Depressive Symptoms

  • Brendel, Matthias Department of Nuclear Medicine, University of Munich, Germany
  • Sauerbeck, Julia Department of Nuclear Medicine, University of Munich, Germany
  • Greven, Sonja Department of Statistics, University of Munich, Germany
  • Kotz, Sebastian Department of Nuclear Medicine, University of Munich, Germany
  • Scheiwein, Franziska Department of Nuclear Medicine, University of Munich, Germany
  • Blautzik, Janusch Department of Nuclear Medicine, University of Munich, Germany
  • Delker, Andreas Department of Nuclear Medicine, University of Munich, Germany
  • Pogarell, Oliver Department of Psychiatry, University of Munich, Germany
  • Ishii, Kazunari Department of Radiology, Kindai University Faculty of Medicine, Osakasayama City, Osaka, Japan
  • Bartenstein, Peter Department of Nuclear Medicine, University of Munich, Germany
  • Rominger, Axel Department of Nuclear Medicine, Inselspital, University Hospital Bern, Switzerland
Show more…
Published in:
  • Journal of Alzheimer's Disease. - IOS Press. - 2018, vol. 65, no. 3, p. 793-806
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/89916
Statistics

Document views: 18 File downloads: